MDT Medtronic Plc

Medtronic and the Medtronic Foundation Commit More Than $1M to Coronavirus Efforts

Medtronic and the Medtronic Foundation Commit More Than $1M to Coronavirus Efforts

Giving Includes Medtronic Foundation Cash Donations to Partners and Product Donations from the Company Including Respirator Masks, Nitrile Gloves, Ventilators and Pulse Oximeters

DUBLIN, Feb. 10, 2020 (GLOBE NEWSWIRE) --   (NYSE:MDT), the global leader in medical technology, today announced it and the Medtronic Foundation are committing approximately $1.2M to coronavirus relief efforts across the globe. These contributions encompass Medtronic Foundation cash contributions and product donations from the company.

Medtronic Foundation is partnering in a local and global response with cash contributions to:

  • International Federation of Red Cross and Red Crescent Societies (IFRC), which is deploying medical teams to areas hardest hit by the virus outbreak
  • CDC Foundation (Centers for Disease Control) to meet fast-emerging needs identified by the CDC to help respond to the public health threat posed by the virus
  • Project HOPE, which is mobilizing and delivering shipments of personal protective equipment (respirator masks, protective suits and nitrile gloves) to hospitals in China

The product donations include:

  • Medtronic products to treat patients with severe respiratory illness, including ventilators, respiratory filters, and pulse oximeters and sensors
  • Medtronic products to support patients undergoing cardiopulmonary bypass surgery, including sensors and centrifugal blood pump systems

Product donations will be sent to Wuhan Huoshenshan Hospital, a new designated hospital to treat Coronavirus patients.

“As a global healthcare leader, Medtronic is committed to helping support impacted communities across the globe,” said Omar Ishrak, Medtronic chairman and chief executive officer. “Our longstanding Mission calls on us to maintain good citizenship as a company as we aim to alleviate pain, restore health, and extend life for people around the world. This guides our work every day and we are determined to do everything we can to care for our employees, their families, and their local communities as we address this global health crisis collectively.”

In addition to these relief efforts, Medtronic is committed to protecting the health and safety of its more than 90,000 employees around the world. The company provides support to employees experiencing hardship during emergencies, while also ensuring regular communication and updates to teams and remains in contact with local health authorities for the most current information.

About Medtronic Foundation

Medtronic plc is the sole funder of Medtronic Foundation, whose focus is on improving health for underserved populations worldwide, as well as supporting communities Medtronic employees live and give. For more information please visit medtronicfoundation.org.

About Medtronic

Medtronic plc (), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-



Erika Winkels

Public Relations

Ryan Weispfenning

Investor Relations

EN
10/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medtronic Plc

Research Team ACF
  • Research Team ACF

KDST + NLSP Combined Core Investment Case 29052025

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod...

Research Team ACF
  • Research Team ACF

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innov...

Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Holding Above Prior Breakout Level Yet Again As discussed throughout the first half of January, we continue to believe that tariffs will mostly be used as a negotiation tactic, and much like Trump's prior presidency, will be much less impactful than feared. We reiterated this in yesterday's pre-market ETF Pathfinder, also noting "we anticipate the Canada/Mexico tariffs to be resolved relatively quickly, and therefore we view the latest pullback as a buying opportunity." Sure enough, bot...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Prior Breakout Level DeepSeek appears to have turned the chatbot market upside-down, putting pressure on AI-linked stocks. While the dust has yet to settle, the good news is that the selloff has been largely contained to these AI-linked stocks. The rest of the market did not seem to care; the equal-weighted S&P 500 was roughly flat yesterday. Additionally, market dynamics remain healthy, with Treasury yields, the U.S. dollar (DXY), and WTI crude oil continuing to move lower, and...

Medtronic, Inc.: Update to credit analysis

Our credit view of this issuer reflects its strong product diversification, offset by its large payouts to shareholders.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch